Browse
We’re here to help

Find guidance on Author Services

Login | Register

Login
Register

Cart Add to Cart

Search
Browse
We’re here to help

Find guidance on Author Services

Home
All Journals
Expert Opinion on Drug Safety
List of Issues
Volume 15, Issue 5

Expert Opinion on Drug Safety

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Opinion on Drug Safety, Volume 15, Issue 5 (2016)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Drug Safety, Volume 15, Issue 5 (2016)

See all volumes and issues

Vol 23, 2024 Vol 22, 2023 Vol 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Vol 16, 2017 Volume 15, 2016 Vol 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

BRAF inhibitors - do we need to worry about kidney injury?

Rimda Wanchoo, Craig Devoe & Kenar D. Jhaveri

Pages: 579-581

Published online: 22 Mar 2016

First Page PreviewforBRAF inhibitors - do we need to worry about kidney injury? | Full Text | References | PDF (249 KB)

2024 Views
9 CrossRef citations
0Altmetric

Free Access

Original Research

Article

Data mining spontaneous adverse drug event reports for safety signals in Singapore – a comparison of three different disproportionality measures

Pei San Ang, Zhaojin Chen, Cheng Leng Chan & Bee Choo Tai

Pages: 583-590

Published online: 07 Apr 2016

AbstractforData mining spontaneous adverse drug event reports for safety signals in Singapore – a comparison of three different disproportionality measures | Full Text | References | PDF (767.3 KB)

411 Views
33 CrossRef citations
0Altmetric

Meta-Analysis

Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: results from a systematic review and meta-analysis of randomized controlled trials

Britta Galling, Alexandra Roldán, Liz Rietschel, Katsuhiko Hagi, Frozan Walyzada, Wei Zheng, Xiao-Lan Cao, Yu-Tao Xiang, John M. Kane & Christoph U. Correll

Pages: 591-612

Published online: 07 Apr 2016

AbstractforSafety and tolerability of antipsychotic co-treatment in patients with schizophrenia: results from a systematic review and meta-analysis of randomized controlled trials | Full Text | References | PDF (1.8 MB)

1022 Views
25 CrossRef citations
0Altmetric

Review

The safety of tumor necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis

Maria Victoria Hernández, Raimon Sanmartí & Juan D. Cañete

Pages: 613-624

Published online: 21 Mar 2016

AbstractforThe safety of tumor necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis | Full Text | References | PDF (1,017.8 KB)

316 Views
15 CrossRef citations
0Altmetric

Review

Recent advances in biomarkers and therapeutic interventions for hepatic drug safety – false dawn or new horizon?

Joanna I. Clarke, James W. Dear & Daniel J. Antoine

Pages: 625-634

Published online: 17 Mar 2016

AbstractforRecent advances in biomarkers and therapeutic interventions for hepatic drug safety – false dawn or new horizon? | Full Text | References | PDF (823.4 KB)

722 Views
37 CrossRef citations
0Altmetric

Review

The safety of treatment options for elderly people with acute myeloid leukemia

Xavier Thomas & Caroline Le Jeune

Pages: 635-645

Published online: 17 Mar 2016

AbstractforThe safety of treatment options for elderly people with acute myeloid leukemia | Full Text | References | PDF (917.6 KB)

403 Views
2 CrossRef citations
0Altmetric

Review

Safety and tolerability of β₃-adrenoceptor agonists in the treatment of overactive bladder syndrome – insight from transcriptosome and experimental studies

Martin C. Michel & Stavros Gravas

Pages: 647-657

Published online: 21 Mar 2016

AbstractforSafety and tolerability of β₃-adrenoceptor agonists in the treatment of overactive bladder syndrome – insight from transcriptosome and experimental studies | Full Text | References | PDF (839.8 KB)

304 Views
37 CrossRef citations
0Altmetric

Review

The safety of mineralocorticoid receptor antagonists (MRAs) in patients with heart failure

Bertram Pitt & Patrick Rossignol

Pages: 659-665

Published online: 11 Apr 2016

AbstractforThe safety of mineralocorticoid receptor antagonists (MRAs) in patients with heart failure | Full Text | References | PDF (612.5 KB)

248 Views
11 CrossRef citations
0Altmetric

Review

The use and risks of antibiotics in critically ill patients

Kerina J. Denny, Menino O. Cotta, Suzanne L. Parker, Jason A. Roberts & Jeffrey Lipman

Pages: 667-678

Published online: 07 Apr 2016

AbstractforThe use and risks of antibiotics in critically ill patients | Full Text | References | PDF (1 MB)

550 Views
22 CrossRef citations
0Altmetric

Review

Cardiovascular safety of antipsychotics: a clinical overview

Christoffer Polcwiartek, Kristian Kragholm, Ole Schjerning, Claus Graff & Jimmi Nielsen

Pages: 679-688

Published online: 01 Apr 2016

AbstractforCardiovascular safety of antipsychotics: a clinical overview | Full Text | References | PDF (868.4 KB)

1918 Views
37 CrossRef citations
0Altmetric

Drug Safety Evaluation

Article

A drug safety evaluation of mirabegron in the management of overactive bladder

Dudley Robinson, Ganesh Thiagamoorthy & Linda Cardozo

Pages: 689-696

Published online: 21 Apr 2016

AbstractforA drug safety evaluation of mirabegron in the management of overactive bladder | Full Text | References | PDF (575.5 KB)

430 Views
16 CrossRef citations
0Altmetric

Article

Saxagliptin for the treatment of diabetes - a focus on safety

Simona Cernea, Avivit Cahn & Itamar Raz

Pages: 697-707

Published online: 21 Mar 2016

AbstractforSaxagliptin for the treatment of diabetes - a focus on safety | Full Text | References | PDF (776.7 KB)

305 Views
6 CrossRef citations
0Altmetric

Article

A safety evaluation of ivacaftor for the treatment of cystic fibrosis

Susanna A. McColley

Pages: 709-715

Published online: 07 Apr 2016

AbstractforA safety evaluation of ivacaftor for the treatment of cystic fibrosis | Full Text | References | PDF (601 KB)

762 Views
15 CrossRef citations
0Altmetric

Article

A review of antidepressant-induced urinary hesitancy: a focus on levomilnacipran ER including two case presentations(5633)

Gregory M. Asnis, Elishka Caneva & Margaret A. Henderson

Pages: 717-725

Published online: 01 Apr 2016

AbstractforA review of antidepressant-induced urinary hesitancy: a focus on levomilnacipran ER including two case presentations(5633) | Full Text | References | PDF (697.7 KB)

249 Views
2 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Association between dual orexin receptor antagonists (DORAs) and suicidality: reports to the United States Food and Drug Administration Adverse Event Reporting System (FAERS)

Roger S. McIntyre et al.

Article | Published online: 3 Jun 2024

Immune checkpoint inhibitors and neurotoxicity: a focus on diagnosis and management for a multidisciplinary approach

Desirèe Speranza et al.

Review Article | Published online: 3 Jun 2024

An overview of the efficacy and safety of β₂-adrenoceptor antagonists for the treatment of chronic obstructive pulmonary disease

Maria Gabriella Matera et al.

Review Article | Published online: 2 Jun 2024

Vaccine-associated paralytic poliomyelitis in oral polio vaccine recipients: disproportionality analysis using VAERS and systematic review

Joylin Emelia Suares et al.

Article | Published online: 30 May 2024

Open Access

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Drug Safety (Vol.15, Iss.5, 2016)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?